Khan, Unab I.
Shah, Sabeen
Viswanathan, Shankar
Qureshi, Asra
Noornabi, Yasmeen
Niaz, Mahnoor
Wylie-Rosett, Judith
Article History
Received: 12 January 2024
Accepted: 18 April 2024
First Online: 27 April 2024
Declarations
:
: We obtained a full-review ethical approval from the Ethics Review Committee (ERC) at Aga Khan University (2022-6723-20985). Written informed consent to participate was obtained from individual FGD participants. Family informed consent is obtained from the family head for all family members willing to participate in HAS. They are also informed of the voluntary nature of participation. A copy of the signed consent form is provided to FGD and HAS participants for record keeping. The privacy of participants is always ensured. Time and place for FGDs were selected within the community, in consideration of cultural norms. To ensure anonymity during FGDs no real names or directly identifying information will be reported. Additionally, FGD participants were informed about the audio recording of the conversation. CHWs have been trained to identify, and link HAS participants with elevated BP readings with FMHC clinical team for immediate care. All participants are provided with the name, telephone number, and email address of the principal investigator.
: Not applicable to the study protocol presented in this manuscript.
: The authors declare no competing interests.